MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 142 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $153,000 | -26.8% | 2,135 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $209,000 | -53.0% | 2,135 | -59.4% | 0.00% | -50.0% |
| Q4 2021 | $445,000 | +5.5% | 5,255 | 0.0% | 0.00% | +33.3% |
| Q3 2021 | $422,000 | -17.6% | 5,255 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $512,000 | -16.7% | 5,255 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $615,000 | +5.3% | 5,255 | 0.0% | 0.01% | -50.0% |
| Q4 2020 | $584,000 | -35.8% | 5,255 | -31.4% | 0.01% | -42.9% |
| Q3 2020 | $909,000 | +4.8% | 7,655 | 0.0% | 0.02% | -19.2% |
| Q2 2020 | $867,000 | +69.7% | 7,655 | 0.0% | 0.03% | +8.3% |
| Q1 2020 | $511,000 | -24.7% | 7,655 | +2.7% | 0.02% | +26.3% |
| Q4 2019 | $679,000 | +4.8% | 7,452 | 0.0% | 0.02% | -24.0% |
| Q3 2019 | $648,000 | -16.1% | 7,452 | +1.1% | 0.02% | -21.9% |
| Q2 2019 | $772,000 | -12.1% | 7,369 | +5.1% | 0.03% | -20.0% |
| Q1 2019 | $878,000 | +64.7% | 7,013 | +48.4% | 0.04% | +73.9% |
| Q4 2018 | $533,000 | -47.5% | 4,727 | -0.3% | 0.02% | -57.4% |
| Q3 2018 | $1,015,000 | – | 4,740 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |